Acadia Pharmaceuticals (ACAD) Net Margin (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Net Margin of 1.36% for Q1 2026, down 641.0% year-over-year from 0.25% in Q1 2025, and down 98.59% quarter-over-quarter from 96.33% in Q4 2025.
Acadia Pharmaceuticals (ACAD) Net Margin (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Net Margin history runs 17 years deep, the most recent figure standing at 1.36% for Q1 2026.
- In Q1 2026, Net Margin fell 641.0% year-over-year to 1.36%; the TTM figure through Mar 2026 stood at 34.3% (up 1132.0% YoY), while the FY2025 annual figure was 36.49%, up 1285.0% from the prior year.
- Net Margin for Q1 2026 stood at 1.36%, down from 96.33% in the prior quarter.
- The five-year high for Net Margin was 96.33% in Q4 2025, with the low at 97.91% in Q1 2022.
- The 5-year median for Net Margin is 7.77% (2025), against an average of 0.62%.
- The sharpest annual moves came in 2022 and 2023: Net Margin tumbled 3555 bps in 2022, then soared 6159 bps in 2023.
- Acadia Pharmaceuticals' Net Margin stood at 30.51% in 2022, then surged by 165 bps to 19.82% in 2023, then surged by 179 bps to 55.37% in 2024, then surged by 74 bps to 96.33% in 2025, then tumbled by 99 bps to 1.36% in 2026.
- Business Quant data shows ACAD's Net Margin at 1.36% in Q1 2026, 96.33% in Q4 2025, and 25.76% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | 10.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.23% |
| Mar 31, 2026 | 1.36% |
| Dec 31, 2025 | 96.33% |
| Sep 30, 2025 | 25.76% |
| Jun 30, 2025 | 10.08% |
| Mar 31, 2025 | 7.77% |
| Dec 31, 2024 | 55.37% |
| Sep 30, 2024 | 13.09% |
| Jun 30, 2024 | 13.80% |
| Mar 31, 2024 | 8.04% |
| Dec 31, 2023 | 19.82% |
| Sep 30, 2023 | -30.79% |
| Jun 30, 2023 | 0.67% |
| Mar 31, 2023 | -36.32% |
| Dec 31, 2022 | -30.51% |
| Sep 30, 2022 | -20.78% |
| Jun 30, 2022 | -25.28% |
| Mar 31, 2022 | -97.91% |
| Dec 31, 2021 | -35.66% |
| Sep 30, 2021 | -10.98% |